12 Month Price Forecast For MOVE
Distance to MOVE Price Forecasts
MOVE Price Momentum
🤔 Considering Movano (MOVE)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 6, 2025 6:42 PM UTC
MOVE Analyst Ratings & Price Targets
Based on our analysis of 2 Wall Street analysts, MOVE has a consensus that is bullish. The median price target is $30.00, with forecasts ranging from $30.00 to $30.00. Currently, there are 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With MOVE currently trading at $5.30, the median price forecast suggests a 466.6% upside. The most optimistic forecast comes from at , projecting a 466.6% upside, while at provides the most conservative target, suggesting a 466.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MOVE Analyst Consensus
MOVE Price Target Range
Latest MOVE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MOVE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Sep 4, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Reiterates | $2.00 |
| Jul 30, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Initiates | $2.00 |
| Oct 1, 2014 | B. Riley Securities | Neutral | Downgrade | $0.00 | |
| Feb 24, 2014 | Morgan Stanley | Equal-Weight | Initiates | $13.00 | |
| Feb 19, 2014 | Morgan Stanley | Equal-Weight | Initiates | $0.00 | |
| Sep 30, 2013 | Benchmark | Buy | Maintains | $23.00 | |
| Aug 2, 2013 | Oppenheimer | Outperform | Maintains | $18.00 | |
| Jul 16, 2013 | Stephens & Co. | Overweight | Initiates | $0.00 | |
| Jun 28, 2013 | B. Riley Securities | Buy | Initiates | $0.00 | |
| Mar 13, 2013 | Benchmark | Buy | Maintains | $14.00 | |
| Jun 26, 2012 | Benchmark | Buy | Initiates | $0.00 |
Stocks Similar to Movano Inc.
The following stocks are similar to Movano based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Movano Inc. (MOVE) Financial Data
Movano Inc. has a market capitalization of $35.12M with a P/E ratio of -0.6x. The company generates $852,000 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -3,198.8% and return on equity of -181.2%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Movano Inc. (MOVE) Company Overview
About Movano Inc.
Develops healthcare solutions via wearable technology.
Movano Inc. generates revenue by creating innovative wearable devices that monitor various health metrics, specifically targeting the needs of women. Their flagship product, the Evie Ring, offers an array of health and wellness tracking features, while the company also explores partnerships and technology licensing for its System-on-a-Chip (SoC) solutions.
Founded in 2018, Movano Inc. transitioned from its previous name, Maestro Sensors Inc., to better reflect its focus on health technology. The company is headquartered in Pleasanton, California, positioning it within a robust tech ecosystem.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
30
CEO
Dr. John Mastrototaro Ph.D.
Country
United States
IPO Year
2021
Website
movano.comMovano Inc. (MOVE) Latest News & Analysis
Movano Health (Nasdaq: MOVE) launched EvieAI, a virtual wellness assistant for its Evie smart ring, utilizing data from medical journals.
Movano Health's release of EvieAI enhances its product offering, potentially increasing market share and consumer interest, which could positively impact stock performance and investor sentiment.
Movano Health (Nasdaq: MOVE) has expanded its board of directors by adding Dr. Shaheen Wirk, an expert in healthcare investment and research.
The addition of Dr. Shaheen Wirk to Movano Health's board could enhance strategic guidance and investor confidence, potentially driving stock performance and company growth.
Movano Health (Nasdaq: MOVE) received FDA 510(k) clearance for its EvieMED Ring pulse oximeter, accessing a $40 billion total addressable market in healthcare B2B opportunities.
Movano Health's FDA 510(k) clearance for its pulse oximeter expands its market potential to $40 billion, signaling growth opportunities and increased investor interest in health tech.
Movano Inc. (MOVE) Q3 2024 Earnings Call Transcript
2 months agoMovano Inc. (NASDAQ: MOVE) will hold its Q3 2024 earnings conference call on November 14, 2024, at 5:00 PM ET, featuring key executives.
Movano Inc.'s Q3 earnings call indicates upcoming financial performance insights, which can influence stock valuation and investor sentiment regarding the company's growth prospects.
Movano Health (Nasdaq: MOVE) reported Q3 2024 results, highlighting successful Evie Ring restock, updates on EvieMED 510(k) review, and plans for B2B opportunities. Conference call at 2 PM PT today.
Movano Health's strong third quarter results and updates on product launches and regulatory reviews signal growth potential, impacting future revenue and stock performance.
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device
2 months agoMovano Health Inc. (Nasdaq: MOVE) has tested a new blood pressure wrist wearable during a hypoxia clinical trial at UCSF, showing significant noise reduction and higher fidelity signals.
Movano Health's advancements in wearable technology could enhance its market position, potentially driving sales and investor interest in future growth.
Frequently Asked Questions About MOVE Stock
What is Movano Inc.'s (MOVE) stock forecast for 2025?
Based on our analysis of 2 Wall Street analysts, Movano Inc. (MOVE) has a median price target of $30.00. The highest price target is $30.00 and the lowest is $30.00.
Is MOVE stock a good investment in 2025?
According to current analyst ratings, MOVE has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.30. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MOVE stock?
Wall Street analysts predict MOVE stock could reach $30.00 in the next 12 months. This represents a 466.6% increase from the current price of $5.30. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Movano Inc.'s business model?
Movano Inc. generates revenue by creating innovative wearable devices that monitor various health metrics, specifically targeting the needs of women. Their flagship product, the Evie Ring, offers an array of health and wellness tracking features, while the company also explores partnerships and technology licensing for its System-on-a-Chip (SoC) solutions.
What is the highest forecasted price for MOVE Movano Inc.?
The highest price target for MOVE is $30.00 from at , which represents a 466.6% increase from the current price of $5.30.
What is the lowest forecasted price for MOVE Movano Inc.?
The lowest price target for MOVE is $30.00 from at , which represents a 466.6% increase from the current price of $5.30.
What is the overall MOVE consensus from analysts for Movano Inc.?
The overall analyst consensus for MOVE is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $30.00.
How accurate are MOVE stock price projections?
Stock price projections, including those for Movano Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
